跳至主要内容
临床试验/NCT06069076
NCT06069076尚未招募不适用

Diagnostic Value of Serum Cathepsin S and Chromogranin A in Diabetic Kidney Disease

Assiut University0 个研究点目标入组 92 人开始时间: 2023年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
92
主要终点
Evulate the diagnostic value of serum cathepsin S and chromogranin A for Diabetic kidney disease.

研究概览

简要总结

  1. Evulate the diagnostic value of serum cathepsin S and chromogranin A for Diabetic kidney disease.
  2. To correlate the levels of serum Cathepsin S and chromogranin A with HbA1c and eGFR in type 2 diabetic patients based on urinary Albumin- Creatinine Ratio.

详细描述

Diabetic nephropathy (DN) is a common and serious complication of diabetes and has been shown to be a major cause of end-stage renal disease (ESRD), requiring costly renal replacement therapy in the form of dialysis or transplantation .

It is appreciated that up to 40% of patients with type 1 and type 2 diabetes mellitus (DM) present DN . Early detection and appropriate treatment are essential to prevent disability and death.

Cathepsin S (Cat-S) was a secreted cysteine proteolytic enzyme that is mainly expressed in macrophages. Macrophages undergoing chemotaxis adhere to the basement membrane of blood vessels and secrete Cat-S, and the secreted Cat-S was involved in hydrolysis of elastin, laminin, collagen and other extracellular matrix components, causing vascular damage .

So, Cathepsin S(Cat-S), a novel non-invasive diagnostic marker mediates vascular endothelial dysfunction.

In recent years, studies have shown that up regulation of Cat-S was associated with the development of IgA nephropathy, lupus nephritis, insulin resistance, diabetes and other renal diseases.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients diagnosed as type 2 Diabetes mellitus
  • Patients with T2DM with normoalbuminuria , microalbuminuria and macroalbuminuria.

排除标准

  • Renal impairment of other Known origin,
  • Type 1 D,
  • Hepatic disease,
  • Heart failure,
  • Thyroid disorders,
  • Autoimmune disorders,
  • Inflammatory condition,
  • Malignancy,
  • Urinary tract infection,
  • Pregnancy.

结局指标

主要结局

Evulate the diagnostic value of serum cathepsin S and chromogranin A for Diabetic kidney disease.

时间窗: Baseline

Evaluation of the clinical utility of the measurement of the level of Cathepsin S and chromogranin A in type 2 diabetic nephropathy.

次要结局

  • correlate the levels of serum Cathepsin S and chromogranin A with HbA1c and eGFR in type 2 diabetic patients based on urinary Albumin- Creatinine Ratio.(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Z A Kamel

principal investigator

Assiut University

相似试验